Target intelligence / Profile preview

Tubulin gamma-1 chain (TUBG1)

Target
TUBG1
Molecular classification
Tubulin family protein, Microtubule nucleation factor, Cytoskeletal protein, Other
01

Overview

Tubulin gamma-1 chain (TUBG1) is a highly conserved component of the tubulin superfamily essential for microtubule nucleation. TUBG1, together with associated proteins (such as GCPs—gamma-complex proteins), forms the gamma-tubulin ring complex (γ-TuRC), a multi-protein assembly that serves as a template for the initiation (nucleation) of new microtubules at microtubule organizing centers (MTOCs), particularly the centrosome[1]. This process is critical for accurate mitotic spindle formation, cell division, and many fundamental cellular processes such as organelle positioning and intracellular transport[1][2]. γ-Tubulin has additional roles in regulating microtubule dynamics, controlling E2F-driven transcription in the nucleus, and participating in DNA damage responses[1][3]. Defects in TUBG1 function or regulation have been implicated in certain cancers and neurodevelopmental conditions, but the protein is not currently considered a direct pharmacological or therapeutic target due to its essential, ubiquitous role in cell biology and the lack of selective modulators[1][3][4].

Other names
TUBG1TUBGGCP-1TUBGCP1Gamma-1-tubulinGamma-tubulin complex component 1CDCBM4tubulin, gamma polypeptidetubulin gamma-1 chain
02

Mechanism of action

Not applicable for drugs, as there are no known direct pharmacological agents targeting TUBG1. (Experimental approaches may include disruption by genetic or protein–protein interaction inhibitors, but these are not clinical drugs.)[1][3].

03

Biological functions

Microtubule nucleationCell divisionSpindle formationCell cycle regulationOrganelle positioningIntracellular transportCentrosome organizationDNA damage responseRegulation of E2F transcription factors
04

Disease associations

CancerNeurodevelopmental disorders (microcephaly)Other
05

Safety considerations

Essential role in cell division means complete inhibition is predicted to have high cytotoxicity in proliferating cellspotential toxicity due to impairment of microtubule and centrosome functionpossible neurodevelopmental impact
06

Biomarkers

TUBG1 expression or mutation may be studied in cancer or neurodevelopmental disorders, but it is not a standard clinical biomarker[1][3].

Beyond the preview

Go deeper on Tubulin gamma-1 chain (TUBG1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tubulin gamma-1 chain (TUBG1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call